The c-Myc oncoprotein interacts with Bcr

Gwendolyn M. Mahon, Yan Wang, Malgorzata Korus, Elena Kostenko, Li Cheng, Tong Sun, Ralph B. Arlinghaus, Ian P. Whitehead

Research output: Contribution to journalArticlepeer-review

20 Scopus citations


Bcr is a multifunctional protein that is the fusion partner for Abl (p210 Bcr-Abl) in Philadelphia chromosome positive leukemias. We have identified c-Myc as a binding partner for Bcr in both yeast and mammalian cells. We are also able to observe interactions between natively expressed c-Myc and Bcr in leukemic cell lines. Although Bcr and Max have overlapping binding sites on c-Myc, Bcr cannot interact with Max, or with the c-Myco•Max heterodimer. Bcr expression blocks activation of c-Myc-responsive genes, as well as the transformed phenotype induced by coexpression of c-Myc and H-Ras, and this finding suggests that one function of Bcr is to limit the activity of c-Myc. However, Bcr does not block c-Myc function by preventing its nuclear localization. Interestingly, increased Bcr dosage in COS-7 and K-562 cells correlates with a reduction in c-Myc protein levels, suggesting that Bcr may in fact be limiting c-Myc activity by regulating its stability. These data indicate that Bcr is a novel regulator of c-Myc function whose disrupted expression may contribute to the high level of c-Myc protein that is observed in Bcr-Abl transformed cells.

Original languageEnglish (US)
Pages (from-to)437-441
Number of pages5
JournalCurrent Biology
Issue number5
StatePublished - Mar 4 2003

All Science Journal Classification (ASJC) codes

  • General Agricultural and Biological Sciences
  • General Biochemistry, Genetics and Molecular Biology


Dive into the research topics of 'The c-Myc oncoprotein interacts with Bcr'. Together they form a unique fingerprint.

Cite this